Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03472131
Other study ID # SPONDYLODISKITIS2018
Secondary ID
Status Completed
Phase N/A
First received March 4, 2018
Last updated March 24, 2018
Start date January 2004
Est. completion date December 2016

Study information

Verified date March 2018
Source University Hospital of Patras
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This retrospective study assess the efficacy and safety of a posterolateral unilateral approach for debridement and titanium cage insertion supplemented by contralateral transfascial screw fixation for sick patients suffering from septic thoracolumbosacral spondylodiskitis. Hematogenous pyogenic spondylodiskitis requires surgical intervention in cases of development of neurological signs, spinal instability, progressive spinal deformity and abscess. When operative treatment is indicated, an anterior approach by open thoracotomy or by a thoraco-abdominal approach or combined anterior and posterior approaches are recommended. In cases of severe sick patients anterior approach is associated with high morbidity and mortality.


Description:

Twenty consecutive sick (ASA>III) patients, 14 men and 6 women, aged 64±14 years, suffering from single level septic thoracolumbosacral spondylodiskitis underwent an one-stage less invasively unilateral posterolateral decompression, insertion of titanium cage& pedicle screw fixation plus contralateral transfascial pedicle screw fixation.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 44 Years to 80 Years
Eligibility Inclusion Criteria:

- Single-level thoracic, thoracolumbar, lumbar or lumbosacral spondylodiskitis

- Medical comorbidities were present in all 20 patients. These included diabetes mellitus, chronic renal insufficiency, advanced heart insufficiency, hypertension, cortisone abuse, drug abuse and/or advanced age (>65y).

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Unilateral Posterolateral Approach and Debridement

Other:
Titanium cage insertion supplemented by screw fixation


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University Hospital of Patras St. Andrew's General Hospital, Patras, Greece

Outcome

Type Measure Description Time frame Safety issue
Primary The extent of spinal cord injury (SCI) defined by the American Spinal Injury Association (ASIA) Impairment Scale Grade A Complete lack of motor and sensory function below the level of injury (including the anal area) Grade B Some sensation below the level of the injury (including anal sensation) Grade C Some muscle movement is spared below the level of injury, but 50 percent of the muscles below the level of injury cannot move against gravity.
Grade D Most (more than 50 percent) of the muscles that are spared below the level of injury are strong enough to move against gravity.
Grade E All neurologic function has returned.
2 years
Secondary Survival rate at 2,5 years Revision surgery or "worst case scenario" 2,5 years
Secondary Survival rate at 10 years Revision surgery or "worst case scenario" 10 years
See also
  Status Clinical Trial Phase
Completed NCT03158766 - Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID)